TriCor Information
What's inside TriCor
TriCor Active Ingredients: fenofibrate, fenofibrate, micronized, details.| TriCor Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| TriCor 48 mg | tablet | oral | 1.0 each | OTC |
| TriCor 54 mg | tablet | oral | 1.0 each | OTC |
| TriCor 160 mg | tablet | oral | 1.0 each | OTC |
| TriCor 145 mg | tablet | oral | 1.0 each | OTC |
| TriCor 67 mg | capsule | oral | 1.0 each | OTC |
| TriCor 200 mg | capsule | oral | 1.0 each | OTC |
| TriCor 134 mg | capsule | oral | 1.0 each | OTC |
Recent TriCor Side Effects
Posted by lando 4 months ago
Man hearing all this really scares me. This is my third meds that they are trying me on. I am going to watch myself very clos...
Posted by its_david 9 months ago
The only thing that I have experienced with Tricor is passing gas. And I don't mean now and then, I am talking about the comp...
Posted by mrquito 10 months ago
Hello,
After taking it for 3 weeks,.....
I feel fatigue, my midsection and sides feel funny (but don't hurt) and I also f...
TriCor in the News
Author : National Association of Professional Insurance Agents - Earthtimes
Straka is Vice President/Commercial Sales Manager of TRICOR, Inc., a PIA member agency in Lancaster, Wisconsin. The PIA National Young Insurance ...
Tue Mar 04 11:38:23 -0500 2008
How to monitor statin side effects - Chicago Daily Herald
Other fibrates, such as TriCor, don't seem to have that effect. Other drugs: Several antibiotics, such as Biaxin, also interact with statins. ...
Mon Mar 10 01:23:51 -0400 2008
Wisconsin's Straka Named Young Agent of Year by PIA National - Insurance Journal
Straka is vice president and commercial sales manager of TRICOR, Inc., a PIA member agency in Lancaster, Wisc. The PIA National Young Insurance Professional ...
Thu Mar 06 01:09:53 -0500 2008
TriCor Chemical Information
fenofibrate - A synthetic phenoxy-isobutyric acid derivate and prodrug with antihyperlipidemic activity. Fenofibrate is hydrolyzed in vivo to its active metabolite fenofibric acid that binds to and activates perioxisome proliferator activated receptor alpha (PPARalpha), resulting in the activation of lipoprotein lipase and reduction of the production of apoprotein C-III, an inhibitor of lipoprotein lipase activity. Increased lipolysis and a fall in plasma triglycerides, in turn, leads to the modification of the small, dense low density lipoporotein (LDL) particles into larger particles that are catabolized more rapidly. In addition, activation of PPARalpha also increases the synthesis of apoproteins A-I, A-II, and high density lipoprotein (HDL)-cholesterol. Overall, fenofibrate reduces total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) while increasing HDL cholesterol.
fenofibrate, micronized
TriCor RSS Feed
